相关实验视频
Updated: Jul 25, 2025

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.3K
循环RNA表达和竞争性内源RNA网络在病理性,与年龄相关的黄斑变性事件中:一个跨平台的正常化研究
Ruxu Sun1, Hongjing Zhu1, Ying Wang1
1Department of Ophthalmology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Journal of biomedical research
|June 27, 2023
概括
研究人员确定了与年龄相关的黄斑退化 (AMD) 相关的关键分子途径. 这项研究的重点是循环RNAs (circRNAs) 及其在视网膜色素上皮质功能障碍中的作用,这是缩性AMD的特征.
科学领域:
- 眼科医生 眼科 眼科
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是50岁以上人群不可逆转失明的主要原因.
- 视网膜色素表皮功能障碍是缩性AMD病变的主要驱动因素.
研究的目的:
- 在缩性AMD中识别差异表达的循环RNA (circRNAs).
- 为缩性AMD构建一个竞争的内源性RNA (ceRNA) 网络.
- 阐明涉及到缩性AMD的分子途径.
主要方法:
- 使用ComBat和训练分布匹配的综合基因表达综合数据.
- 在集成测序数据上进行基因组丰富分析.
- 构建了AMD细胞模型以识别circRNAs并构建了一个ceRNA网络.
主要成果:
- 确定过氧体,瘤亡因子-α (TNF-α) 信号传导和核因子kappa B (NF-κB) 途径.
- 该ceRNA网络包括7个circRNA,15个microRNA和82个mRNA.
- 基因和基因组分析的京都百科全书揭示了低氧诱导因子-1 (HIF-1) 信号通路作为一个常见的下游事件.
结论:
- 已识别的circRNAs和途径提供了对缩性AMD的潜在见解.
- 构建的ceRNA网络突出显示了AMD中复杂的调控相互作用.
- 这些发现可能有助于了解缩性AMD的病理机制.
相关概念视频
Nonsense-mediated mRNA Decay
10.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.7K
Nuclear Export of mRNA
7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K
Regulation of Expression Occurs at Multiple Steps
22.8K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

